The landscape of pharmaceutical research and development is continually shaped by the availability of high-quality chemical building blocks. 1,3-Propanedisulfonic Acid, identified by CAS 21668-77-9, is one such compound that plays a vital role in the synthesis of advanced pharmaceutical agents. As a leading manufacturer and supplier in China, we offer this critical intermediate to the global market.

This article aims to provide a comprehensive overview of 1,3-Propanedisulfonic Acid, covering its key chemical properties and diverse applications. With a molecular formula of C3H8O6S2 and a molecular weight of 204.21, this disulfonic acid is characterized by its colorless to light yellow clear liquid appearance when supplied in aqueous solution (typically 50-70% purity). Its structure makes it a valuable intermediate for complex organic synthesis pathways.

The primary application of 1,3-Propanedisulfonic Acid in the pharmaceutical industry is its use as a precursor for compounds like Eprodisate. Eprodisate is being investigated for its ability to inhibit the progression of amyloid-related diseases by disrupting the interaction between amyloidogenic proteins and cell surface molecules. This therapeutic angle highlights the importance of sourcing reliable, high-purity 1,3-Propanedisulfonic Acid for ongoing research and potential clinical applications.

For procurement managers and research scientists looking to buy this chemical, partnering with a reputable Chinese manufacturer offers significant advantages. We ensure stringent quality control measures are in place throughout our production process, guaranteeing consistent batch-to-batch quality. Our competitive pricing and commitment to supply chain integrity make us an ideal partner for your chemical sourcing needs.

We invite you to contact us for detailed product specifications, sample requests, and a quotation for 1,3-Propanedisulfonic Acid. Leveraging our expertise as a chemical supplier, you can confidently acquire this essential intermediate, supporting your innovative pharmaceutical projects.